SlideShare une entreprise Scribd logo
1  sur  24
Dr Rai Muhammad Asghar
Professor of Paediatrics
RGH Rawalpindi
PERTUSSIS
Pertussis
(Whooping Cough)
* Pertussis : Intense Cough
* Highly Infectious disease
Etiology:
* Bordetella Pertussis
* B.Parapertussis
* B. Bronchiseptica
Epidemiology:
* World wide
* 1922-1948--- leading causes of death
* Endemic---Epidemic cycles
* Extremely contagious-attack rate 100%
* Immunity is never complete
* Protection begins to wane in 3-5 yrs after
vaccination
* Unmeasurable after 12 yrs
* Adolescents & adults are major Reservoir
* Age : 1-5 yrs
* Incubation period : 7-10 days
* Infectivity : first 4 weeks
* Transmission by droplet
Pathophysiology:
* B. Pertussis produces many biologically
active substances
* Inflammation of respiratory mucosa
* Patchy necrosis
* Tenacious mucopurulant exudate
* Bronchiolar obstruction :
Atelectasis, Bronchiectasis
Clinical Features:
* Pertussis is a 6 weeks disease
* CATARRHAL STAGE (1-2 WKS)
* Nonspecific features
* Congestion, Rhinorrhoea
* Sneezing
* Lacrimation, Conjunctival redness
* Low grade fever, mild cough
Paroxysmal Stage ( 2-4 wks)
* Cough is first dry & intermittent
* Inexorable paroxysm
* Machine-gun burst of uninterrupted cough
* Series of coughing in single expiration
* Eyes bulging—watering
* Chin & Chest held forward
* Tongue protruding maximally
* Face-Red-Blue
* Whoop at the end of paroxysm
* Post tussive emesis
* Number & Severity of Paroxysm
progress over days to weeks
Infants < 3 months
* No classical stages
* well appearing infants begins to choke
* Gasp & flail extremities
* Reddend face
* Cough may not be prominent
* Woop infrequent
* Immunized children have fore-shortening
of all stages
* Adults have no distinct stages
* Number & severity of paroxysm progress
& remain at that plateau
* Physical examination is unremarkable
Convalescent Stage ( 1-2 wks)
* Episodes of cough becomes less frequent
* Less severe
* Paroxysms of whooping disappear
Diagnosis:
*Clinical Diagnosis
Paroxysmal stage
* Suspect if predominant complaint is
cough especially following are absent
- Fever
- Malaise, Myalgias
- Rash
- Sore throat
- Hoarseness
- Tachypnea
- Wheeze
- Crepitations/ Rales
Investigations:
1. Blood Count
Absolute Lymphocytosis
(15,000-100,000 cells/mm3
)
2. Flourescent antibody staining
3. Cultures:
Nasopharyngeal aspirate
4. X-Ray chest
Complications:
1. Respiratory
2. Sequelae of forceful cough
3. CNS
1.Respiratory
- Apnea
- Bronchopneumonia
- Atelectasis
- Bronchiectasis
- Emphysema—Interstitial / Subcutaneous
- Otitis media
- Reactivation of quiescent tuberculosis
2. Sequelae of forceful cough
- Epistaxis, sub-conjunctival hemorrhage
- Intracranial Bleeding
- Rectal prolapse, umbilical hernias
- Dehydration, Malnutrition
- Tetany
3. CNS
- Convulsions…..Hypoxemia,
Hemorrhage
- Encephalopathy
Treatment:
Specific
* Erythromycin 40-50 mg/kg/day for 14 d
* Clarithromycin 15 mg/kg for 7 d
*Azithromycin 10 mg/kg for 5 d
* Ineffective if given in paroxysmal stage
General Measures
* Young infants should be hospitalized
* Adequate hydration, Nutrition
* Oxygen
* Gentle suction
* Cough syrup have no role
Prevention:
* Pertussis vaccine is part of DPT vaccine
* All household contacts should get
Erythromycin for 14 days
* Close contacts < 7 yr should get booster
* If documented pertussis infection exempt
from routine pertussis vaccination
Thank You

Contenu connexe

Tendances (20)

Measles
MeaslesMeasles
Measles
 
Whooping cough (pertussis)
Whooping cough (pertussis)Whooping cough (pertussis)
Whooping cough (pertussis)
 
Measles
MeaslesMeasles
Measles
 
bronchiolitis in paediatrics
bronchiolitis in paediatricsbronchiolitis in paediatrics
bronchiolitis in paediatrics
 
Mumps
MumpsMumps
Mumps
 
Pneumonia
PneumoniaPneumonia
Pneumonia
 
Pneumonia in children
Pneumonia in childrenPneumonia in children
Pneumonia in children
 
Bronchopneumonia (1)
Bronchopneumonia (1)Bronchopneumonia (1)
Bronchopneumonia (1)
 
Bronchitis
BronchitisBronchitis
Bronchitis
 
Measles
MeaslesMeasles
Measles
 
Meningococcal infection
Meningococcal infectionMeningococcal infection
Meningococcal infection
 
Pulmonary tuberculosis ppt
Pulmonary tuberculosis pptPulmonary tuberculosis ppt
Pulmonary tuberculosis ppt
 
Bronchial asthma in children
Bronchial asthma in children Bronchial asthma in children
Bronchial asthma in children
 
Bacterial meningitis
Bacterial meningitisBacterial meningitis
Bacterial meningitis
 
Tonsillitis
TonsillitisTonsillitis
Tonsillitis
 
Pneumonia in children
Pneumonia in children Pneumonia in children
Pneumonia in children
 
Meningitis in children
Meningitis  in children Meningitis  in children
Meningitis in children
 
PAEDIATRICS HIV
PAEDIATRICS HIVPAEDIATRICS HIV
PAEDIATRICS HIV
 
Measles
MeaslesMeasles
Measles
 
Smallpox disease
Smallpox diseaseSmallpox disease
Smallpox disease
 

Similaire à Pertussis

Similaire à Pertussis (20)

Pertussis
PertussisPertussis
Pertussis
 
Epidemiology and Control Measure for Pertussis whooping c
Epidemiology and Control Measure for Pertussis whooping cEpidemiology and Control Measure for Pertussis whooping c
Epidemiology and Control Measure for Pertussis whooping c
 
Seminar on measles and influenza
Seminar on measles and influenza Seminar on measles and influenza
Seminar on measles and influenza
 
BRONCHIOLITIS pdf.pdf
BRONCHIOLITIS pdf.pdfBRONCHIOLITIS pdf.pdf
BRONCHIOLITIS pdf.pdf
 
Pertussis
PertussisPertussis
Pertussis
 
PNEUMONIA.pptx
PNEUMONIA.pptxPNEUMONIA.pptx
PNEUMONIA.pptx
 
Pneumonia and it's management
Pneumonia and it's managementPneumonia and it's management
Pneumonia and it's management
 
Bronchiolitis.pptx
Bronchiolitis.pptxBronchiolitis.pptx
Bronchiolitis.pptx
 
Pertussis
PertussisPertussis
Pertussis
 
Pertusis
PertusisPertusis
Pertusis
 
Whooping Cough infectious diseases presentation
Whooping Cough infectious diseases presentationWhooping Cough infectious diseases presentation
Whooping Cough infectious diseases presentation
 
Whooping cough
Whooping coughWhooping cough
Whooping cough
 
Approach to chronic cough
Approach to chronic coughApproach to chronic cough
Approach to chronic cough
 
Bordetella pertussis
Bordetella pertussisBordetella pertussis
Bordetella pertussis
 
PNEUMONIA.pptx
PNEUMONIA.pptxPNEUMONIA.pptx
PNEUMONIA.pptx
 
BRONCHIOLITIS.pptx
BRONCHIOLITIS.pptxBRONCHIOLITIS.pptx
BRONCHIOLITIS.pptx
 
Bronchitis and pneumonia 2022_Sizova.pdf
Bronchitis and pneumonia 2022_Sizova.pdfBronchitis and pneumonia 2022_Sizova.pdf
Bronchitis and pneumonia 2022_Sizova.pdf
 
Chronic obstructive pulmonary disease
Chronic obstructive pulmonary diseaseChronic obstructive pulmonary disease
Chronic obstructive pulmonary disease
 
Childhood pneumonia
Childhood pneumoniaChildhood pneumonia
Childhood pneumonia
 
Care of the Child.ppt
Care of the Child.pptCare of the Child.ppt
Care of the Child.ppt
 

Plus de Rawalpindi Medical College

Plus de Rawalpindi Medical College (20)

Nephrotic syndrome.
Nephrotic syndrome.Nephrotic syndrome.
Nephrotic syndrome.
 
Symptomtology of cardiovascular diseases
Symptomtology of cardiovascular diseasesSymptomtology of cardiovascular diseases
Symptomtology of cardiovascular diseases
 
Symptomatology-GIT-1
Symptomatology-GIT-1Symptomatology-GIT-1
Symptomatology-GIT-1
 
Symptomatology-GIT
Symptomatology-GITSymptomatology-GIT
Symptomatology-GIT
 
Symptomalogy in RENAL impairement
Symptomalogy in RENAL impairementSymptomalogy in RENAL impairement
Symptomalogy in RENAL impairement
 
History taking
History takingHistory taking
History taking
 
Right bundle branch block
Right bundle branch blockRight bundle branch block
Right bundle branch block
 
Right and left ventricular hypertrophy
Right and left ventricular hypertrophyRight and left ventricular hypertrophy
Right and left ventricular hypertrophy
 
Rheumatoid arthritis 2
Rheumatoid arthritis 2Rheumatoid arthritis 2
Rheumatoid arthritis 2
 
Systemic lupus erythematosus
Systemic lupus erythematosusSystemic lupus erythematosus
Systemic lupus erythematosus
 
Supraventricular tachyarrythmias
Supraventricular tachyarrythmiasSupraventricular tachyarrythmias
Supraventricular tachyarrythmias
 
Supraventricular tacchycardias
Supraventricular tacchycardias Supraventricular tacchycardias
Supraventricular tacchycardias
 
Skin-
Skin-Skin-
Skin-
 
Skin
Skin  Skin
Skin
 
Sick sinus syndrome-2
Sick sinus syndrome-2Sick sinus syndrome-2
Sick sinus syndrome-2
 
Sick sinus syndrome
Sick sinus syndrome Sick sinus syndrome
Sick sinus syndrome
 
X rays
X raysX rays
X rays
 
Ventricular arrhythmias
Ventricular arrhythmias Ventricular arrhythmias
Ventricular arrhythmias
 
Ventricular tachyarrhythmias
Ventricular tachyarrhythmias Ventricular tachyarrhythmias
Ventricular tachyarrhythmias
 
antiplatelet effect of aspirin
antiplatelet effect of aspirinantiplatelet effect of aspirin
antiplatelet effect of aspirin
 

Dernier

Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3JemimahLaneBuaron
 
BAG TECHNIQUE Bag technique-a tool making use of public health bag through wh...
BAG TECHNIQUE Bag technique-a tool making use of public health bag through wh...BAG TECHNIQUE Bag technique-a tool making use of public health bag through wh...
BAG TECHNIQUE Bag technique-a tool making use of public health bag through wh...Sapna Thakur
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactPECB
 
social pharmacy d-pharm 1st year by Pragati K. Mahajan
social pharmacy d-pharm 1st year by Pragati K. Mahajansocial pharmacy d-pharm 1st year by Pragati K. Mahajan
social pharmacy d-pharm 1st year by Pragati K. Mahajanpragatimahajan3
 
APM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across SectorsAPM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across SectorsAssociation for Project Management
 
IGNOU MSCCFT and PGDCFT Exam Question Pattern: MCFT003 Counselling and Family...
IGNOU MSCCFT and PGDCFT Exam Question Pattern: MCFT003 Counselling and Family...IGNOU MSCCFT and PGDCFT Exam Question Pattern: MCFT003 Counselling and Family...
IGNOU MSCCFT and PGDCFT Exam Question Pattern: MCFT003 Counselling and Family...PsychoTech Services
 
General AI for Medical Educators April 2024
General AI for Medical Educators April 2024General AI for Medical Educators April 2024
General AI for Medical Educators April 2024Janet Corral
 
Interactive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationInteractive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationnomboosow
 
9548086042 for call girls in Indira Nagar with room service
9548086042  for call girls in Indira Nagar  with room service9548086042  for call girls in Indira Nagar  with room service
9548086042 for call girls in Indira Nagar with room servicediscovermytutordmt
 
Measures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SDMeasures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SDThiyagu K
 
Sanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfSanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfsanyamsingh5019
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdfQucHHunhnh
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityGeoBlogs
 
The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13Steve Thomason
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxVishalSingh1417
 
Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingTechSoup
 
microwave assisted reaction. General introduction
microwave assisted reaction. General introductionmicrowave assisted reaction. General introduction
microwave assisted reaction. General introductionMaksud Ahmed
 
Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeThiyagu K
 

Dernier (20)

Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3
 
BAG TECHNIQUE Bag technique-a tool making use of public health bag through wh...
BAG TECHNIQUE Bag technique-a tool making use of public health bag through wh...BAG TECHNIQUE Bag technique-a tool making use of public health bag through wh...
BAG TECHNIQUE Bag technique-a tool making use of public health bag through wh...
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global Impact
 
social pharmacy d-pharm 1st year by Pragati K. Mahajan
social pharmacy d-pharm 1st year by Pragati K. Mahajansocial pharmacy d-pharm 1st year by Pragati K. Mahajan
social pharmacy d-pharm 1st year by Pragati K. Mahajan
 
APM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across SectorsAPM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across Sectors
 
Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1
 
IGNOU MSCCFT and PGDCFT Exam Question Pattern: MCFT003 Counselling and Family...
IGNOU MSCCFT and PGDCFT Exam Question Pattern: MCFT003 Counselling and Family...IGNOU MSCCFT and PGDCFT Exam Question Pattern: MCFT003 Counselling and Family...
IGNOU MSCCFT and PGDCFT Exam Question Pattern: MCFT003 Counselling and Family...
 
General AI for Medical Educators April 2024
General AI for Medical Educators April 2024General AI for Medical Educators April 2024
General AI for Medical Educators April 2024
 
Interactive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationInteractive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communication
 
9548086042 for call girls in Indira Nagar with room service
9548086042  for call girls in Indira Nagar  with room service9548086042  for call girls in Indira Nagar  with room service
9548086042 for call girls in Indira Nagar with room service
 
Measures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SDMeasures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SD
 
Sanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfSanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdf
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activity
 
The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptx
 
Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy Consulting
 
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
 
microwave assisted reaction. General introduction
microwave assisted reaction. General introductionmicrowave assisted reaction. General introduction
microwave assisted reaction. General introduction
 
Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and Mode
 

Pertussis

  • 1. Dr Rai Muhammad Asghar Professor of Paediatrics RGH Rawalpindi
  • 3. Pertussis (Whooping Cough) * Pertussis : Intense Cough * Highly Infectious disease
  • 4. Etiology: * Bordetella Pertussis * B.Parapertussis * B. Bronchiseptica
  • 5. Epidemiology: * World wide * 1922-1948--- leading causes of death * Endemic---Epidemic cycles * Extremely contagious-attack rate 100% * Immunity is never complete * Protection begins to wane in 3-5 yrs after vaccination
  • 6. * Unmeasurable after 12 yrs * Adolescents & adults are major Reservoir * Age : 1-5 yrs * Incubation period : 7-10 days * Infectivity : first 4 weeks * Transmission by droplet
  • 7. Pathophysiology: * B. Pertussis produces many biologically active substances * Inflammation of respiratory mucosa * Patchy necrosis * Tenacious mucopurulant exudate * Bronchiolar obstruction : Atelectasis, Bronchiectasis
  • 8. Clinical Features: * Pertussis is a 6 weeks disease * CATARRHAL STAGE (1-2 WKS) * Nonspecific features * Congestion, Rhinorrhoea * Sneezing * Lacrimation, Conjunctival redness * Low grade fever, mild cough
  • 9. Paroxysmal Stage ( 2-4 wks) * Cough is first dry & intermittent * Inexorable paroxysm * Machine-gun burst of uninterrupted cough * Series of coughing in single expiration * Eyes bulging—watering * Chin & Chest held forward * Tongue protruding maximally
  • 10. * Face-Red-Blue * Whoop at the end of paroxysm * Post tussive emesis * Number & Severity of Paroxysm progress over days to weeks
  • 11. Infants < 3 months * No classical stages * well appearing infants begins to choke * Gasp & flail extremities * Reddend face * Cough may not be prominent * Woop infrequent
  • 12. * Immunized children have fore-shortening of all stages * Adults have no distinct stages * Number & severity of paroxysm progress & remain at that plateau * Physical examination is unremarkable
  • 13. Convalescent Stage ( 1-2 wks) * Episodes of cough becomes less frequent * Less severe * Paroxysms of whooping disappear
  • 15. * Suspect if predominant complaint is cough especially following are absent - Fever - Malaise, Myalgias - Rash - Sore throat - Hoarseness - Tachypnea - Wheeze - Crepitations/ Rales
  • 16. Investigations: 1. Blood Count Absolute Lymphocytosis (15,000-100,000 cells/mm3 ) 2. Flourescent antibody staining 3. Cultures: Nasopharyngeal aspirate 4. X-Ray chest
  • 17. Complications: 1. Respiratory 2. Sequelae of forceful cough 3. CNS
  • 18. 1.Respiratory - Apnea - Bronchopneumonia - Atelectasis - Bronchiectasis - Emphysema—Interstitial / Subcutaneous - Otitis media - Reactivation of quiescent tuberculosis
  • 19. 2. Sequelae of forceful cough - Epistaxis, sub-conjunctival hemorrhage - Intracranial Bleeding - Rectal prolapse, umbilical hernias - Dehydration, Malnutrition - Tetany
  • 21. Treatment: Specific * Erythromycin 40-50 mg/kg/day for 14 d * Clarithromycin 15 mg/kg for 7 d *Azithromycin 10 mg/kg for 5 d * Ineffective if given in paroxysmal stage
  • 22. General Measures * Young infants should be hospitalized * Adequate hydration, Nutrition * Oxygen * Gentle suction * Cough syrup have no role
  • 23. Prevention: * Pertussis vaccine is part of DPT vaccine * All household contacts should get Erythromycin for 14 days * Close contacts < 7 yr should get booster * If documented pertussis infection exempt from routine pertussis vaccination